Consensus Report From the Miami Liver Proton Therapy Conference

An international group of 22 liver cancer experts from 18 institutions met in Miami, Florida to discuss the optimal utilization of proton beam therapy (PBT) for primary and metastatic liver cancer. There was consensus that PBT may be preferred for liver cancer patients expected to have a suboptimal therapeutic ratio from XRT, but that PBT should not be preferred for all patients. Various clinical scenarios demonstrating appropriateness of PBT vs. XRT were reviewed.

[1]  S. Apisarnthanarax,et al.  Proton Beam Therapy and Carbon Ion Radiotherapy for Hepatocellular Carcinoma. , 2018, Seminars in radiation oncology.

[2]  Jeffrey W. Clark,et al.  Phase II Study of Proton-Based Stereotactic Body Radiation Therapy for Liver Metastases: Importance of Tumor Genotype , 2017, Journal of the National Cancer Institute.

[3]  I. Hyodo,et al.  Long‐term outcomes of proton beam therapy in patients with previously untreated hepatocellular carcinoma , 2017, Cancer science.

[4]  Lipika Goyal,et al.  Multi-Institutional Phase II Study of High-Dose Hypofractionated Proton Beam Therapy in Patients With Localized, Unresectable Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  P. Bhosale,et al.  Ablative Radiotherapy Doses Lead to a Substantial Prolongation of Survival in Patients With Inoperable Intrahepatic Cholangiocarcinoma: A Retrospective Dose Response Analysis. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  L. Dawson,et al.  Predictors of Liver Toxicity Following Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma. , 2015, International journal of radiation oncology, biology, physics.

[7]  T. Zhu,et al.  Clinical decision tool for optimal delivery of liver stereotactic body radiation therapy: Photons versus protons. , 2015, Practical radiation oncology.

[8]  L. Dawson,et al.  Outcomes following definitive stereotactic body radiotherapy for patients with Child-Pugh B or C hepatocellular carcinoma. , 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[9]  Zahra Kassam,et al.  Sequential phase I and II trials of stereotactic body radiotherapy for locally advanced hepatocellular carcinoma. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  R. T. Ten Haken,et al.  Radiation-associated liver injury. , 2010, International journal of radiation oncology, biology, physics.

[11]  R. T. Ten Haken,et al.  Individualized Adaptive Stereotactic Body Radiotherapy for Liver Tumors in Patients at High Risk for Liver Damage: A Phase 2 Clinical Trial , 2018, JAMA oncology.

[12]  Andrew Jackson,et al.  Local Control After Stereotactic Body Radiation Therapy for Liver Tumors. , 2018, International journal of radiation oncology, biology, physics.